Skip to main content
KMPHARMACEUTICAL Co.,Ltd. logo

KMPHARMACEUTICAL Co.,Ltd. — Investor Relations & Filings

Ticker · 225430 ISIN · KR7225430008 KO Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2025-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 225430

About KMPHARMACEUTICAL Co.,Ltd.

https://en.kmkmp.com/

KMPHARMACEUTICAL Co., Ltd. is a company that develops, manufactures, and distributes personal care products. Its core business areas include oral care solutions, such as toothpaste and toothbrushes; beauty and skincare products; and a dedicated line of items for infants and children. The company leverages its research and development expertise to provide Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, creating customized products tailored to client needs in the oral care and cosmetics sectors. It focuses on developing innovative solutions and adheres to strict quality standards, particularly for its children's product lines.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '케이엠제약(주)' (KM Pharmaceutical Co., Ltd.) covering the period from January 1, 2025, to June 30, 2025. It contains detailed corporate information, financial data, management discussion, and governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and provides the outcome of the voting on agenda items (specifically, the amendment of the articles of incorporation). This falls directly under the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-07-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of a major shareholder (Kang Il-mo) and their special related parties in the company 'KM Pharmaceutical Co., Ltd.' (케이엠제약(주)). It specifically reports on changes in collateralized stock contracts (주식담보대출 만기 연장). This type of filing is classified as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-07-08 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) issued by KM Pharmaceutical Co., Ltd. It contains the meeting agenda, date, location, electronic voting procedures, and detailed management reference materials (such as board activity, director remuneration, and major shareholder transactions). This document is a standard proxy statement/notice of meeting provided to shareholders to inform them of upcoming voting items and provide necessary background information for their decision-making.
2025-07-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This document details the shareholding status, changes in ownership, and collateral agreements of a major shareholder (Kang Il-mo) in KM Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-06-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (Extraordinary General Meeting). It does not contain the full proxy materials or the meeting results, but rather serves as a formal notice of the record date for shareholder rights. Given the nature of the announcement as a regulatory disclosure regarding corporate governance and shareholder meetings, it fits best under the general regulatory filing category.
2025-06-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.